Edwards Lifesciences

Dr. Ming H. Wu, Former Senior Vice President of Engineering at Edwards Lifesciences, Joins Medeologix as Board Member and Advisor

Retrieved on: 
Monday, October 9, 2023
Senior, Knowledge, Biology, Engineering, American Institute for Medical and Biological Engineering, Materials Science and Engineering B, Biomedical engineering, Medicine, UCLA, Champaign–Urbana metropolitan area, University, Aluminium alloy, Doctor of Philosophy, AIMBE, Fairfield University, Journal, Materials science, ASTM, ASM, Material, Publication, Biomedicine, Science, Memory, Edwards Lifesciences, Face, Research, Medical device, Pseudoelasticity, Nickel titanium

Throughout his illustrious career at Edwards Lifesciences, he played a pivotal role in advancing cutting-edge technologies in heart valve design, testing and manufacturing.

Key Points: 
  • Throughout his illustrious career at Edwards Lifesciences, he played a pivotal role in advancing cutting-edge technologies in heart valve design, testing and manufacturing.
  • A reliable partner like Medeologix, with its efficient one-stop approach and expertise in design for manufacturability and scaled-up manufacturing, is device industry's ideal collaborator.
  • With Dr. Wu's joining as a board member and advisor, Medeologix is able to further enhance its technology capability and industry networking, and demonstrate its dedication to serving customers' needs.
  • His affiliation and involvement in Shape Memory and Superelasticity (SMST) has helped shape the field of materials science and engineering for medical device applications.

InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives

Retrieved on: 
Tuesday, October 3, 2023
Stroke, KOL, Medical Affairs Bureau, Employment, Cheryl, TCAR, McKesson Corporation, Edwards Lifesciences, Change Healthcare, TAL, TEL, NSPR, Biometrics, Quality assurance, CAS, Growth, EPS, Regulatory affairs, Compensated emancipation, Pharmaceutical industry, Management, Medical device, MD

TEL AVIV, Israel and MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced senior leadership additions and changes intended to support the company’s commercial growth initiatives, including potential approval of the CGuard Prime stent platform in the U.S., development of new stent delivery systems, and growth in existing approved territories outside of the U.S.

Key Points: 
  • In addition, Shane Gleason, who previously served as InspireMD’s General Manager of North America and VP of Global Marketing, has been promoted to Chief Commercial Officer.
  • “I am very excited to announce these additions to our leadership team and I look forward to each of their contributions,” Mr. Slosman concluded.
  • Earlier in his career, he held senior leadership positions at Sunshine Heart, Neomend, Abbott Vascular (part of Abbott) and Guidant (acquired by Abbott), among others.
  • Cheryl Tal joins InspireMD from New Phase Ltd., where she served as Director of Regulatory Affairs.

Blood Pressure Transducers Market to grow by USD 128.65 million from 2022 to 2027, North America to account for 36% of market growth- Technavio

Retrieved on: 
Wednesday, September 20, 2023
Prevalence, Maharashtra University of Health Sciences, MHealth, Patient, EHR, Masimo, Hospice and palliative medicine, Telehealth, Clinical data management, UGO, Reusability, Attention, USD, Hypertension, BP, Growth, Diagnosis, Clifton Springs Hospital & Clinic, Disposable product, Hospital, Biotechnology, HOB GmbH & Co KG, FREE, Edwards Lifesciences, Research, Blood pressure, ROW, Abdominal ultrasonography, Pharmaceutical industry, Medical device, Geography

NEW YORK, Sept. 20, 2023 /PRNewswire/ -- The blood pressure transducers market is expected to grow by USD 128.65 million from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 20, 2023 /PRNewswire/ -- The blood pressure transducers market is expected to grow by USD 128.65 million from 2022 to 2027.
  • The market is segmented by Product (Disposable blood pressure transducers and Reusable blood pressure transducers), End-user (Hospitals, Clinics, and ASCs), and Geography (North America, Europe, Asia, and the Rest of the World (ROW)).
  • Some of the key countries that are contributing significantly to the growth of the blood pressure (BP) probe market in North America are the US and Canada.
  • Growth of the blood pressure transducers market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of the blood pressure transducer market companies.

LifeScience Logistics’ Lakeland Facility Becomes Vital Hub for Hurricane Disaster Relief Operations in Florida

Retrieved on: 
Saturday, September 2, 2023
Pharmaceutical, Medical Devices, Law Enforcement, Emergency Services, Environment, Science, Biotechnology, Transport, Natural Disasters, Logistics, Supply Chain Management, Other Science, Health, Public Policy, Government, Travel, Professional, Bureau, ACHA, Leon County Emergency Medical Services, Ambulance, Florida Department, MRE, Edwards Lifesciences, Agency, LSL, Nursing, Tropical cyclone

This week, a Lakeland, FL warehouse facility operated by LifeScience Logistics emerged as a crucial staging and dispatch center for Hurricane disaster relief efforts in Florida.

Key Points: 
  • This week, a Lakeland, FL warehouse facility operated by LifeScience Logistics emerged as a crucial staging and dispatch center for Hurricane disaster relief efforts in Florida.
  • Thomas DiBernardo, coordinator of Florida CARES (Bureau of Emergency Medical Oversight) and his team arrived at the facility on the afternoon of August 28th.
  • Each ambulance was equipped with a two-person crew and dispatched as needed to support evacuation and relief efforts.
  • LSL worked in close coordination with state emergency management teams to provide vital support and resources during this challenging time.

BetterInvesting™ Magazine Update on Edwards Lifesciences Corp. and 3M Company

Retrieved on: 
Tuesday, August 29, 2023
CFA, 3M, NAIC, Committee, Undervalued stock, Edwards Lifesciences, National Association, NYSE, Pharmaceutical industry, Security (finance)

TROY, Mich., Aug. 29, 2023 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Edwards Lifesciences Corp. (NYSE:EW) as its "Stock to Study" and 3M Company (NYSE:MMM) as its "Undervalued Stock" in the November 2023 issue for investors' informational and educational use.

Key Points: 
  • TROY, Mich., Aug. 29, 2023 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Edwards Lifesciences Corp. (NYSE:EW) as its "Stock to Study" and 3M Company (NYSE:MMM) as its "Undervalued Stock" in the November 2023 issue for investors' informational and educational use.
  • To learn more about fundamental analysis, visit https://www.betterinvesting.org/learn-about-investing/investor-education...
    Check the November 2023 issue of BetterInvesting Magazine for more details about the latest stocks.
  • Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Edwards Lifesciences Corp. and 3M Company by viewing their fundamental data and applying judgments.
  • Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

California Life Sciences appoints Brent Fisk as Senior Vice President of Government Relations and External Affairs

Retrieved on: 
Monday, July 10, 2023
Senior, Horizon Therapeutics, Edwards Lifesciences, CLS, Public policy, State government, Government, Organization, Patient, Centers for Medicare & Medicaid Services, Foreign policy, Therapy, Horizon, Pharmaceutical industry

Washington, D.C., July 10, 2023 (GLOBE NEWSWIRE) -- California Life Sciences (CLS), the trade association representing California’s life sciences sector , announces Brent Fisk as Senior Vice President of Government Relations and External Affairs, effective July 10.

Key Points: 
  • Washington, D.C., July 10, 2023 (GLOBE NEWSWIRE) -- California Life Sciences (CLS), the trade association representing California’s life sciences sector , announces Brent Fisk as Senior Vice President of Government Relations and External Affairs, effective July 10.
  • “For over a decade, Brent has played a valuable role in shaping and executing legislative efforts for California life sciences companies," said Mike Guerra, CLS president and CEO.
  • Fisk joins CLS from Horizon Therapeutics where he worked to shape critical healthcare policies on issues related to orphan drugs, Medicare/Medicaid, and critical access.
  • “CLS member companies are making incredible strides to bring innovative solutions for healthier lives for all patients,” Fisk said.

LifeSci Communications Bolsters Leadership Team

Retrieved on: 
Wednesday, April 26, 2023
LSC, Bristol Myers Squibb, Edwards Lifesciences, Wheeler, Omnicom Group, Patient, Bird, Sanofi, Growth, Merck, AofA—International Meeting on Combinatorial, Probabilistic, and Asymptotic Methods in the Analysis of Algorithms, Environment, Talazoparib, Pharmaceutical industry, Science, Pfizer

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- LifeSci Communications (LSC) today announced the appointment of Tim Bird as executive vice president, client services and Sarah Wheeler , senior vice president, medical communications.

Key Points: 
  • NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- LifeSci Communications (LSC) today announced the appointment of Tim Bird as executive vice president, client services and Sarah Wheeler , senior vice president, medical communications.
  • Bird will lead LifeSci’s growing client roster and expanding team; and Wheeler will help accelerate the growth of the agency’s medical communication services.
  • He brings more than 30 years of experience in brand communications, corporate communications and reputation building.
  • “It’s exciting to leverage our unique heritage in integrated communications to support novel advances for patients.”
    Previously, Wheeler was executive vice president at BGB Group.

$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 20, 2023
Health, Medical Devices, Cardiology, Heart failure, Prevalence, Boston Scientific, Abbott Laboratories, ECMO, CAD, SHD, Incidence, Medtronic, Edwards Lifesciences, MicroPort, Investment, Developed country, Medical tourism, Geography, Medical device, Pharmaceutical industry

The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
  • The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029.
  • Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.
  • The heart failure devices market based on products is segmented as cardiac rhythm products, cardiac assist devices (CAD), structural heart devices (SHD), ECMO and others (modulation devices).

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

Retrieved on: 
Thursday, March 9, 2023
Medical Devices, Health, Surgery, Biometrics, Health Technology, Cardiology, Transesophageal echocardiogram, Peking University, Neurosurgery, Doppler effect, SVV, Patient, Pediatrics International, PI, MASI, PPV, PVI, Cardiac output, CI, Fluid, Heart rate, AUROC, Multimedia, FDA, Edwards Lifesciences, Stroke, Anesthesia, Medical imaging, Medical device, Masimo

The researchers enrolled 60 patients, aged 1-3, who were undergoing major neurosurgery with mechanical ventilation set at a fixed tidal volume of 8 ml/kg.

Key Points: 
  • The researchers enrolled 60 patients, aged 1-3, who were undergoing major neurosurgery with mechanical ventilation set at a fixed tidal volume of 8 ml/kg.
  • The researchers concluded, “Volume-based PVI and ∆Vpeak showed acceptable reliabilities to predict fluid responsiveness, defined by a CI increase, after anesthesia induction in mechanically ventilated young children undergoing major neurosurgery.
  • Accuracy of PVi in predicting fluid responsiveness is variable and influenced by numerous patient, procedure and device related factors.
  • Fluid management decisions should be based on a complete assessment of the patient’s condition and should not be based solely on PVi.

EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Retrieved on: 
Thursday, January 5, 2023
Conference, NYSE, Edwards Lifesciences, Pharmaceutical industry, Management

IRVINE, Calif., Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023.

Key Points: 
  • IRVINE, Calif., Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023.
  • Michael A. Mussallem, chairman and chief executive officer, is scheduled to present at 11:15 a.m. PT.
  • Bernard Zovighian, president and incoming chief executive officer, and Scott Ullem, chief financial officer, will also participate in the conference.
  • A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/ , with an archived version accessible later the same day.